MindMaze is pioneering digital neurotherapeutics, building a universal platform for brain health and recovery.

They provide evidence-driven therapy and assessment portfolios powered by medical-grade software, tailored interactive content, and proprietary peripherals.

The Medicine category offers next-generation evidence-based, protocolized therapies designed for the restoration of motor, cognitive, and cardiovascular function following neural injuries, degeneration, and aging.

Care provides therapies and technologies that enable clinicians to maximize the delivery of motor and cognitive neurorehabilitation across the continuum of care.

Monitor offers diversified digital assessments for high fidelity, reliable quantification of motor and cognitive recovery in patients.

MindMaze is also pioneering teleneurorehabilitation with their MindMotion™ GO programme, enabling neurological patients to access therapy from home at leading sites across the US and Europe.

They develop novel digital therapies that are immersive, scientifically rigorous, and emotionally engaging to enhance neurorehabilitation.

MindMaze combines digital therapeutics with state-of-the-art motion analytics, cloud, AI technologies, and innovative peripherals creating a scalable platform adaptable to all clinical and patient needs.

With regulatory approvals, issued and pending patents, and a presence in multiple countries, MindMaze is making a profound impact on brain repair and neurorehabilitation globally.

Headquarters: Chemin de Roseneck 5, 1006 Lausanne, Switzerland

Phone: +41 21 552 08 01

Email: [email protected]

LinkedIn: https://www.linkedin.com/company/mindmaze